2555 материалов по теме, собраны автоматически из проверенных источников
The immune system possesses legions of T cells that, if primed, could hunt down and destroy tumors. Now, a UC San Francisco team has invented a way to do this by combining immune cells grown in the lab with samples from a patient's tumor. Like giving a scent to a hound dog, it shows the immune system how to go after…
Назван продукт, вещество из которого способно замедлить развитие рака груди Поиск - новости науки и техники
В онкоцентре Челябинска рассказали, какие опухоли можно найти с помощью УЗИ 1obl.
В Новосибирской области создано экологическое движение против рака КПРФ в Новосибирске
People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells. These CD4 cytotoxic T cells became more common with age and often expanded into large groups of nearly identical cells, suggesting the immune system was repeatedly responding to persistent…
Двигатель для китайской многоразовой ракеты «Синъюнь-2» прошёл огневой тест hightech.plus
The FDA is seeking feedback on a potential way of regulating medical devices equipped with generative AI features, informed by the process of training human clinicians. Described as a “competency-based approach,” the process would evaluate AI-equipped devices in increasingly clinical scenarios, including potentially…
Of more than 1,300 AI medical devices cleared by the FDA, only three tested for patient-centered outcomes like death and morbidity, data show. AI integration into healthcare is rapidly progressing. Medical societies like the AMA have called for stricter regulations due to concerns about bias and transparency in…
Heidi Overton, MD, PhD, has been nominated to lead the FDA. The pick from President Donald J. Trump comes months after Martin Makary, MD, resigned from the position in May. Trump made the announcement in a Truth Social post Wednesday, calling Overton “a ROCKSTAR” in the administration, “where she has worked directly…
CMS has updated its guidance on prior authorization metrics reporting, addressing the AMA’s concerns about how health insurers were disclosing requirements and outcomes, according to the organization. The AMA said it notified CMS about issues with reporting metrics after it conducted a review examining how 15 Medicare…